These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 19473460

  • 1. Vardenafil modulates bladder contractility through cGMP-mediated inhibition of RhoA/Rho kinase signaling pathway in spontaneously hypertensive rats.
    Morelli A, Filippi S, Sandner P, Fibbi B, Chavalmane AK, Silvestrini E, Sarchielli E, Vignozzi L, Gacci M, Carini M, Vannelli GB, Maggi M.
    J Sex Med; 2009 Jun; 6(6):1594-1608. PubMed ID: 19473460
    [Abstract] [Full Text] [Related]

  • 2. Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats.
    Morelli A, Filippi S, Comeglio P, Sarchielli E, Chavalmane AK, Vignozzi L, Fibbi B, Silvestrini E, Sandner P, Gacci M, Carini M, Vannelli GB, Maggi M.
    J Sex Med; 2010 Jan; 7(1 Pt 1):107-20. PubMed ID: 19889145
    [Abstract] [Full Text] [Related]

  • 3. Vardenafil and resveratrol synergistically enhance the nitric oxide/cyclic guanosine monophosphate pathway in corpus cavernosal smooth muscle cells and its therapeutic potential for erectile dysfunction in the streptozotocin-induced diabetic rat: preliminary findings.
    Fukuhara S, Tsujimura A, Okuda H, Yamamoto K, Takao T, Miyagawa Y, Nonomura N, Okuyama A.
    J Sex Med; 2011 Apr; 8(4):1061-71. PubMed ID: 21269399
    [Abstract] [Full Text] [Related]

  • 4. Characterization and functional role of androgen-dependent PDE5 activity in the bladder.
    Filippi S, Morelli A, Sandner P, Fibbi B, Mancina R, Marini M, Gacci M, Vignozzi L, Vannelli GB, Carini M, Forti G, Maggi M.
    Endocrinology; 2007 Mar; 148(3):1019-29. PubMed ID: 17138653
    [Abstract] [Full Text] [Related]

  • 5. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
    Toque HA, Priviero FB, Zemse SM, Antunes E, Teixeira CE, Webb RC.
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
    [Abstract] [Full Text] [Related]

  • 6. Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
    Albersen M, Linsen L, Tinel H, Sandner P, Van Renterghem K.
    J Sex Med; 2013 May; 10(5):1268-77. PubMed ID: 23421435
    [Abstract] [Full Text] [Related]

  • 7. Testosterone/estradiol ratio regulates NO-induced bladder relaxation and responsiveness to PDE5 inhibitors.
    Vignozzi L, Filippi S, Morelli A, Comeglio P, Cellai I, Sarchielli E, Maneschi E, Mancina R, Gacci M, Vannelli GB, Maggi M.
    J Sex Med; 2012 Dec; 9(12):3028-40. PubMed ID: 23057807
    [Abstract] [Full Text] [Related]

  • 8. Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats.
    Comeglio P, Cellai I, Filippi S, Corno C, Corcetto F, Morelli A, Maneschi E, Maseroli E, Mannucci E, Fambrini M, Maggi M, Vignozzi L.
    J Sex Med; 2016 Dec; 13(12):1858-1871. PubMed ID: 27914563
    [Abstract] [Full Text] [Related]

  • 9. Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract.
    Fibbi B, Morelli A, Vignozzi L, Filippi S, Chavalmane A, De Vita G, Marini M, Gacci M, Vannelli GB, Sandner P, Maggi M.
    J Sex Med; 2010 Jan; 7(1 Pt 1):59-69. PubMed ID: 19796053
    [Abstract] [Full Text] [Related]

  • 10. Phosphodiesterase type 5 inhibition reverts prostate fibroblast-to-myofibroblast trans-differentiation.
    Zenzmaier C, Kern J, Sampson N, Heitz M, Plas E, Untergasser G, Berger P.
    Endocrinology; 2012 Nov; 153(11):5546-55. PubMed ID: 22948216
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of the relaxant effect of vardenafil in rat penile arteries.
    Sánchez A, Villalba N, Martínez AC, García-Sacristán A, Hernández M, Prieto D.
    Eur J Pharmacol; 2008 May 31; 586(1-3):283-7. PubMed ID: 18420189
    [Abstract] [Full Text] [Related]

  • 12. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
    Fibbi B, Morelli A, Marini M, Zhang XH, Mancina R, Vignozzi L, Filippi S, Chavalmane A, Silvestrini E, Colli E, Adorini L, Vannelli GB, Maggi M.
    J Androl; 2008 May 31; 29(1):70-84. PubMed ID: 17699803
    [Abstract] [Full Text] [Related]

  • 13. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
    Saenz de Tejada I, Angulo J, Cuevas P, Fernández A, Moncada I, Allona A, Lledó E, Körschen HG, Niewöhner U, Haning H, Pages E, Bischoff E.
    Int J Impot Res; 2001 Oct 31; 13(5):282-90. PubMed ID: 11890515
    [Abstract] [Full Text] [Related]

  • 14. [Effects and mechanisms of phosphodiesterase type 5 inhibitors on rats with overactive bladder].
    Chen HD, Ye XT, Weng ZL, Li CD.
    Zhonghua Yi Xue Za Zhi; 2011 Jul 26; 91(28):2001-5. PubMed ID: 22093899
    [Abstract] [Full Text] [Related]

  • 15. Powerful relaxation of phosphodiesterase type 4 inhibitor rolipram in the pig and human bladder neck.
    Ribeiro ASF, Fernandes VS, Martínez-Sáenz A, Martínez P, Barahona MV, Orensanz LM, Blaha I, Serrano-Margüello D, Bustamante S, Carballido J, García-Sacristán A, Prieto D, Hernández M.
    J Sex Med; 2014 Apr 26; 11(4):930-941. PubMed ID: 24754330
    [Abstract] [Full Text] [Related]

  • 16. Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation.
    Morelli A, Chavalmane AK, Filippi S, Fibbi B, Silvestrini E, Sarchielli E, Zhang XH, Vignozzi L, Vannelli GB, Forti G, Maggi M.
    J Sex Med; 2009 Jan 26; 6(1):91-106. PubMed ID: 19170840
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor.
    Kim NN, Huang YH, Goldstein I, Bischoff E, Traish AM.
    Life Sci; 2001 Sep 28; 69(19):2249-56. PubMed ID: 11669467
    [Abstract] [Full Text] [Related]

  • 18. Vardenafil-induced relaxation and cyclic nucleotide levels in normal and obstructed rat urinary bladder.
    Werkström V, Hedlund P, Lee T, Andersson KE.
    BJU Int; 2009 Dec 28; 104(11):1740-5. PubMed ID: 19694713
    [Abstract] [Full Text] [Related]

  • 19. In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.
    Gratzke C, Uckert S, Kedia G, Reich O, Schlenker B, Seitz M, Becker AJ, Stief CG.
    Urol Res; 2007 Feb 28; 35(1):49-54. PubMed ID: 17102958
    [Abstract] [Full Text] [Related]

  • 20. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L, Radovits T, Szabó G, Mózes MM, Rosivall L, Kökény G.
    Nephrol Dial Transplant; 2013 Jul 28; 28(7):1751-61. PubMed ID: 23203993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.